Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy of Enavogliflozin on Exercise Performance and Diastolic Function in Heart Failure With Preserved Ejection Fraction: A Randomized Controlled Trial

NCT06350487 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT06350487
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06350487 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy of Enavogliflozin on Exercise Performance and Diastolic Function in Heart Failure With Preserved Ejection Fraction: A Randomized Controlled Trial
Lead sponsor
Samsung Medical Center
Phase
Phase 4
Overall status
Unknown status
Start date
May 1, 2024
Completion date
June 30, 2026
Enrollment
154 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, preserved ejection fraction